美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CervoMed

2.61

-0.1200-4.40%

盤後：2.670.0600+2.30%19:58 EDT

成交量：44.85萬

成交額：117.66萬

市值：3,946.09萬

市盈率：-0.82

高：2.82

開：2.82

低：2.55

收：2.73

52周最高：11.25

52周最低：2.13

股本：1,511.91萬

流通股本：1,119.72萬

量比：0.97

換手率：4.01%

股息：- -

股息率：- -

每股收益(TTM):-3.1959

每股收益(LYR):-2.9824

淨資產收益率：-107.62%

總資產收益率：-60.80%

市淨率：1.72

市盈率(LYR):-0.88

資料載入中...

總覽公司新聞資訊公告

CervoMed 在 AAIC 2026 公布 Neflamapimod 治療路易體痴呆的新臨床、血漿生物標誌物及影像學數據

CervoMed宣佈完成Neflamapimod針對非流利變異型原發性進行性失語症（一種額顳葉痴呆）的二期研究入組

CervoMed完成1000萬美元納斯達克規則下普通股註冊直接發行

CervoMed宣佈根據納斯達克規則進行1000萬美元普通股市場價註冊直接發行

CervoMed獲得新美國專利，保護Neflamapimod用於純路易體痴呆患者至2042年

CervoMed宣佈私募融資計劃將聚焦戰略合作以推進Neflamapimod進入路易體痴呆症三期臨床

CervoMed計劃於2026年下半年啓動Neflamapimod針對DLB患者的III期臨床試驗

CervoMed將於2026年路易體痴呆協會年會公布Neflamapimod臨床項目進展並參與生物標誌物專題討論

BUZZ-CervoMed 因實驗性藥物在早期痴呆症患者中顯示出療效而上漲

CervoMed於2026年Ad/Pd™科學會議公布新數據，進一步證實Neflamapimod對無阿爾茨海默病共病理的路易體痴呆患者具有積極療效

CervoMed確定針對路易體痴呆症患者的三期臨床試驗配方及給藥方案

Cervomed Inc.盤中異動股價大漲5.14%

CervoMed旗下Neflamapimod獲選納入英國Experts-ALS平台，旨在優先推進肌萎縮側索硬化症的潛力療法

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CRVO/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRVO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRVO\",,,,,undefined,":{"symbol":"CRVO","market":"US","secType":"STK","nameCN":"CervoMed","latestPrice":2.61,"timestamp":1786996800000,"preClose":2.73,"halted":0,"volume":448464,"hourTrading":{"tag":"盘后","latestPrice":2.67,"preClose":2.61,"latestTime":"19:58 EDT","volume":15353,"amount":40990.6471,"timestamp":1787011105154,"change":0.06,"changeRate":0.022989,"amplitude":0.02682},"delay":0,"changeRate":-0.043956043956043994,"floatShares":11197200,"shares":15119100,"eps":-3.195903,"marketStatus":"已收盤","change":-0.12,"latestTime":"08-17 16:00:00 EDT","open":2.82,"high":2.82,"low":2.55,"amount":1176628.26984,"amplitude":0.098901,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.195903,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787040000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":2.73,"preHourTrading":{"tag":"盘前","latestPrice":2.88,"preClose":2.73,"latestTime":"09:04 EDT","volume":1526,"amount":4318.8552904,"timestamp":1786971870652,"change":0.15,"changeRate":0.054945,"amplitude":0.113553},"postHourTrading":{"tag":"盘后","latestPrice":2.67,"preClose":2.61,"latestTime":"19:58 EDT","volume":15353,"amount":40990.6471,"timestamp":1787011105154,"change":0.06,"changeRate":0.022989,"amplitude":0.02682},"volumeRatio":0.971545},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRVO\",,,,,undefined,":{"symbol":"CRVO","floatShares":11197200,"roa":"-60.80%","roe":"-107.62%","lyrEps":-2.982424,"volumeRatio":0.971545,"shares":15119100,"dividePrice":0,"high":2.82,"amplitude":0.098901,"preClose":2.73,"low":2.55,"week52Low":2.13,"pbRate":"1.72","psRate":"119.11","week52High":11.25,"institutionHeld":0,"latestPrice":2.61,"eps":-3.195903,"divideRate":0,"volume":448464,"delay":0,"ttmEps":-3.195903,"open":2.82,"prevYearClose":7.9,"prevWeekClose":2.73,"prevMonthClose":2.58,"prevQuarterClose":3.1,"fiveDayClose":2.86,"twentyDayClose":2.79,"sixtyDayClose":3.24},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRVO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"CRVO","fiscalQuarterEnding":"2026/03","expectedEps":-0.9,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-0.86},{"market":"US","date":"2026-03-13","symbol":"CRVO","fiscalQuarterEnding":"2025/12","expectedEps":-0.79,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773374400000,"reportTimeType":"post","actualEps":-0.88},{"market":"US","date":"2025-11-07","symbol":"CRVO","fiscalQuarterEnding":"2025/09","expectedEps":-0.68,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2025-08-08","symbol":"CRVO","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"pre","actualEps":-0.7},{"market":"US","date":"2025-05-12","symbol":"CRVO","fiscalQuarterEnding":"2025/03","expectedEps":-0.6,"name":null,"time":"盤前","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.56}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRVO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRVO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":6,"updateTime":1766289600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRVO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRVO","date":"2026-08-14","current":-0.816671,"percent":0.857337,"low":-119.682483,"twenty":-34.113333,"median":-4.141074,"eighty":-1.56639,"high":-0.69356,"avg":-16.884215,"sd":23.312306,"marketCap":44298951},"quantilePoints":[{"date":"2023-09-01","current":-5.788607,"twenty":-5.849231,"median":-5.813052,"eighty":-5.769051,"marketCap":33591560},{"date":"2023-09-08","current":-5.135433,"twenty":-5.817941,"median":-5.700604,"eighty":-4.975855,"marketCap":29801161},{"date":"2023-09-15","current":-4.791246,"twenty":-5.769051,"median":-5.182368,"eighty":-4.935961,"marketCap":27803825},{"date":"2023-09-22","current":-4.51746,"twenty":-5.708427,"median":-5.1589,"eighty":-4.822536,"marketCap":26215035},{"date":"2023-09-29","current":-4.66902,"twenty":-5.505043,"median":-5.045475,"eighty":-4.536234,"marketCap":27094543},{"date":"2023-10-06","current":-5.250814,"twenty":-5.262548,"median":-5.040586,"eighty":-4.536234,"marketCap":30470722},{"date":"2023-10-13","current":-6.893527,"twenty":-5.817941,"median":-5.065031,"eighty":-4.595684,"marketCap":40003462},{"date":"2023-10-20","current":-8.995809,"twenty":-6.690143,"median":-5.197035,"eighty":-4.691783,"marketCap":52203100},{"date":"2023-10-27","current":-9.201148,"twenty":-7.153624,"median":-5.22148,"eighty":-4.714546,"marketCap":53394692},{"date":"2023-11-03","current":-8.379791,"twenty":-8.309389,"median":-5.27037,"eighty":-4.77036,"marketCap":48628322},{"date":"2023-11-10","current":-9.709606,"twenty":-8.530373,"median":-5.764162,"eighty":-4.78929,"marketCap":56345302},{"date":"2023-11-17","current":-41.851906,"twenty":-9.287195,"median":-5.866832,"eighty":-4.791246,"marketCap":55950767},{"date":"2023-11-24","current":-43.761983,"twenty":-9.977525,"median":-6.385068,"eighty":-4.83818,"marketCap":58504301},{"date":"2023-12-01","current":-41.597229,"twenty":-22.855354,"median":-7.177091,"eighty":-4.969206,"marketCap":55610296},{"date":"2023-12-08","current":-37.39506,"twenty":-39.737313,"median":-7.68555,"eighty":-5.041564,"marketCap":49992521},{"date":"2023-12-15","current":-37.352614,"twenty":-39.16082,"median":-8.389569,"eighty":-5.054275,"marketCap":49935776},{"date":"2023-12-22","current":-28.736045,"twenty":-38.685423,"median":-8.477572,"eighty":-5.063075,"marketCap":38416500},{"date":"2023-12-29","current":-26.825968,"twenty":-38.401034,"median":-8.868694,"eighty":-5.079111,"marketCap":35862966},{"date":"2024-01-05","current":-39.899383,"twenty":-38.549596,"median":-9.044699,"eighty":-5.121353,"marketCap":53340488},{"date":"2024-01-12","current":-39.88198,"twenty":-39.488419,"median":-9.670494,"eighty":-5.172981,"marketCap":53317222},{"date":"2024-01-19","current":-38.625999,"twenty":-39.313626,"median":-10.04206,"eighty":-5.199968,"marketCap":51638132},{"date":"2024-01-26","current":-38.965567,"twenty":-39.313626,"median":-10.775414,"eighty":-5.223436,"marketCap":52092093},{"date":"2024-02-02","current":-34.593614,"twenty":-39.237223,"median":-27.727949,"eighty":-5.242992,"marketCap":46247338},{"date":"2024-02-09","current":-43.719537,"twenty":-39.237223,"median":-28.736045,"eighty":-5.262548,"marketCap":58447556},{"date":"2024-02-16","current":-68.677874,"twenty":-39.888941,"median":-31.961952,"eighty":-5.505043,"marketCap":91813733},{"date":"2024-02-23","current":-59.169936,"twenty":-40.466999,"median":-34.275268,"eighty":-5.692782,"marketCap":79102808},{"date":"2024-03-01","current":-63.372175,"twenty":-41.597229,"median":-35.401364,"eighty":-5.759273,"marketCap":84720676},{"date":"2024-03-08","current":-73.849585,"twenty":-41.945287,"median":-36.142899,"eighty":-5.808163,"marketCap":98727664},{"date":"2024-03-15","current":-76.245081,"twenty":-43.210183,"median":-36.501144,"eighty":-5.849231,"marketCap":101930142},{"date":"2024-03-22","current":-103.758666,"twenty":-50.901256,"median":-37.320992,"eighty":-6.027192,"marketCap":138712367},{"date":"2024-03-28","current":-90.558053,"twenty":-57.709789,"median":-37.373837,"eighty":-6.291199,"marketCap":121064797},{"date":"2024-04-05","current":-61.481111,"twenty":-59.566286,"median":-37.479952,"eighty":-6.48676,"marketCap":133529165},{"date":"2024-04-12","current":-71.595379,"twenty":-59.997513,"median":-38.212361,"eighty":-6.942417,"marketCap":155496070},{"date":"2024-04-19","current":-71.737433,"twenty":-62.930842,"median":-38.413768,"eighty":-7.153624,"marketCap":155804594},{"date":"2024-04-26","current":-94.969175,"twenty":-65.856384,"median":-38.647222,"eighty":-7.237715,"marketCap":206260987},{"date":"2024-05-03","current":-91.738931,"twenty":-67.584491,"median":-38.965567,"eighty":-7.396119,"marketCap":199245307},{"date":"2024-05-10","current":-90.826862,"twenty":-70.379394,"median":-39.220244,"eighty":-7.806798,"marketCap":197264409},{"date":"2024-05-17","current":-48.426621,"twenty":-71.185147,"median":-39.390029,"eighty":-8.309389,"marketCap":201061130},{"date":"2024-05-24","current":-37.632017,"twenty":-70.941929,"median":-39.252477,"eighty":-8.383702,"marketCap":156243317},{"date":"2024-05-31","current":-37.651896,"twenty":-70.600999,"median":-39.231253,"eighty":-8.399347,"marketCap":156325854},{"date":"2024-06-07","current":-38.148885,"twenty":-69.492975,"median":-39.142864,"eighty":-8.458016,"marketCap":158389289},{"date":"2024-06-14","current":-37.791053,"twenty":-68.677874,"median":-39.132924,"eighty":-8.477572,"marketCap":156903616},{"date":"2024-06-21","current":-39.600094,"twenty":-68.284435,"median":-39.132924,"eighty":-8.688778,"marketCap":164414520},{"date":"2024-06-28","current":-34.033815,"twenty":-67.93606,"median":-39.122984,"eighty":-8.944963,"marketCap":141304045},{"date":"2024-07-05","current":-30.813326,"twenty":-67.00636,"median":-39.083225,"eighty":-9.025143,"marketCap":127932985},{"date":"2024-07-12","current":-31.707906,"twenty":-66.374913,"median":-38.90211,"eighty":-9.138568,"marketCap":131647168},{"date":"2024-07-19","current":-32.304293,"twenty":-66.254136,"median":-38.668445,"eighty":-9.459288,"marketCap":134123291},{"date":"2024-07-26","current":-27.89103,"twenty":-66.009803,"median":-38.625997,"eighty":-9.678316,"marketCap":115799986},{"date":"2024-08-02","current":-21.131978,"twenty":-65.799563,"median":-38.413768,"eighty":-9.715473,"marketCap":87737266},{"date":"2024-08-09","current":-18.460659,"twenty":-64.992694,"median":-38.255401,"eighty":-10.106595,"marketCap":93102198},{"date":"2024-08-16","current":-29.88401,"twenty":-63.82037,"median":-38.148885,"eighty":-10.558342,"marketCap":150713310},{"date":"2024-08-23","current":-26.709039,"twenty":-63.123956,"median":-37.878225,"eighty":-10.740213,"marketCap":134701053},{"date":"2024-08-30","current":-30.47318,"twenty":-62.875574,"median":-37.791053,"eighty":-10.88395,"marketCap":153684657},{"date":"2024-09-06","current":-23.484969,"twenty":-62.310952,"median":-37.632017,"eighty":-13.958048,"marketCap":118441183},{"date":"2024-09-13","current":-28.656572,"twenty":-61.520597,"median":-37.39506,"eighty":-19.017097,"marketCap":144523004},{"date":"2024-09-20","current":-27.560062,"twenty":-60.889782,"median":-37.352614,"eighty":-20.363844,"marketCap":138992998},{"date":"2024-09-27","current":-24.761504,"twenty":-59.992238,"median":-37.044217,"eighty":-21.696558,"marketCap":124879101},{"date":"2024-10-04","current":-23.484969,"twenty":-59.885067,"median":-36.618159,"eighty":-21.737099,"marketCap":118441183},{"date":"2024-10-11","current":-22.093874,"twenty":-59.702244,"median":-36.256014,"eighty":-21.195966,"marketCap":111425503},{"date":"2024-10-18","current":-23.40314,"twenty":-59.499033,"median":-36.121676,"eighty":-21.422875,"marketCap":118028496},{"date":"2024-10-25","current":-22.42119,"twenty":-59.246339,"median":-35.506843,"eighty":-21.041389,"marketCap":113076251},{"date":"2024-11-01","current":-20.964631,"twenty":-58.949205,"median":-34.593614,"eighty":-21.041389,"marketCap":105730422},{"date":"2024-11-08","current":-20.522754,"twenty":-58.467774,"median":-33.995368,"eighty":-20.604583,"marketCap":103501912},{"date":"2024-11-15","current":-7.440484,"twenty":-58.205855,"median":-32.960319,"eighty":-20.319817,"marketCap":88892790},{"date":"2024-11-22","current":-6.632186,"twenty":-57.268349,"median":-31.876883,"eighty":-19.75356,"marketCap":79235913},{"date":"2024-11-29","current":-7.461209,"twenty":-55.646905,"median":-31.638328,"eighty":-10.811593,"marketCap":89140402},{"date":"2024-12-06","current":-8.228056,"twenty":-54.314096,"median":-31.509111,"eighty":-9.711562,"marketCap":98302055},{"date":"2024-12-13","current":-1.31262,"twenty":-52.81792,"median":-30.753634,"eighty":-9.005587,"marketCap":15682107},{"date":"2024-12-20","current":-1.540602,"twenty":-48.999152,"median":-30.455494,"eighty":-8.411081,"marketCap":18405842},{"date":"2024-12-27","current":-1.658046,"twenty":-48.426621,"median":-29.978384,"eighty":-8.228056,"marketCap":19808978},{"date":"2025-01-03","current":-1.609687,"twenty":-47.997222,"median":-29.785815,"eighty":-7.657262,"marketCap":19231216},{"date":"2025-01-10","current":-1.457699,"twenty":-47.144687,"median":-29.245398,"eighty":-7.393795,"marketCap":17415393},{"date":"2025-01-17","current":-1.457699,"twenty":-44.916349,"median":-28.653863,"eighty":-7.183487,"marketCap":17415393},{"date":"2025-01-24","current":-1.59587,"twenty":-43.761983,"median":-28.638191,"eighty":-7.010773,"marketCap":19066141},{"date":"2025-01-31","current":-1.561327,"twenty":-43.745005,"median":-28.566935,"eighty":-6.6764,"marketCap":18653454},{"date":"2025-02-07","current":-1.526784,"twenty":-43.24863,"median":-27.889204,"eighty":-6.348881,"marketCap":18240767},{"date":"2025-02-14","current":-1.609687,"twenty":-42.503822,"median":-27.789183,"eighty":-5.849231,"marketCap":19231216},{"date":"2025-02-21","current":-1.575144,"twenty":-42.386727,"median":-27.612716,"eighty":-5.677137,"marketCap":18818529},{"date":"2025-02-28","current":-1.54751,"twenty":-42.123561,"median":-27.159099,"eighty":-5.235169,"marketCap":18488379},{"date":"2025-03-07","current":-1.526784,"twenty":-42.013202,"median":-26.709039,"eighty":-5.079111,"marketCap":18240767},{"date":"2025-03-14","current":-4.449091,"twenty":-41.962266,"median":-26.52242,"eighty":-4.902715,"marketCap":53154092},{"date":"2025-03-21","current":-7.633919,"twenty":-41.885863,"median":-26.463551,"eighty":-4.893488,"marketCap":124361854},{"date":"2025-03-28","current":-5.06435,"twenty":-41.817949,"median":-26.005308,"eighty":-4.799924,"marketCap":82501776},{"date":"2025-04-04","current":-5.919092,"twenty":-41.665143,"median":-25.710723,"eighty":-4.841604,"marketCap":96426126},{"date":"2025-04-11","current":-4.538149,"twenty":-41.597229,"median":-25.473418,"eighty":-4.783424,"marketCap":73929597},{"date":"2025-04-17","current":-5.235298,"twenty":-41.597229,"median":-25.219748,"eighty":-4.791246,"marketCap":85286646},{"date":"2025-04-25","current":-4.61561,"twenty":-41.512337,"median":-24.761504,"eighty":-4.727795,"marketCap":75191492},{"date":"2025-05-02","current":-5.475694,"twenty":-41.298141,"median":-24.40964,"eighty":-4.781468,"marketCap":89202869},{"date":"2025-05-09","current":-4.535478,"twenty":-40.703923,"median":-23.894115,"eighty":-4.754506,"marketCap":73886084},{"date":"2025-05-16","current":-4.092569,"twenty":-40.111614,"median":-23.509518,"eighty":-4.701084,"marketCap":76409872},{"date":"2025-05-23","current":-3.924764,"twenty":-39.899383,"median":-23.40314,"eighty":-4.546794,"marketCap":73276893},{"date":"2025-05-30","current":-3.631106,"twenty":-39.899383,"median":-22.993995,"eighty":-4.534221,"marketCap":67794181},{"date":"2025-06-06","current":-3.514575,"twenty":-39.885461,"median":-22.735979,"eighty":-4.503786,"marketCap":65618501},{"date":"2025-06-13","current":-3.551865,"twenty":-39.7837,"median":-22.503019,"eighty":-4.258784,"marketCap":66314718},{"date":"2025-06-20","current":-3.258207,"twenty":-39.75913,"median":-22.404825,"eighty":-4.158521,"marketCap":60832005},{"date":"2025-06-27","current":-3.311811,"twenty":-39.663708,"median":-22.077508,"eighty":-4.077653,"marketCap":61832818},{"date":"2025-07-03","current":-2.633601,"twenty":-39.550025,"median":-21.823837,"eighty":-3.980044,"marketCap":49170362},{"date":"2025-07-11","current":-3.360754,"twenty":-39.440965,"median":-21.455606,"eighty":-3.896797,"marketCap":62746603},{"date":"2025-07-18","current":-3.528559,"twenty":-39.386585,"median":-21.072854,"eighty":-3.646022,"marketCap":65879582},{"date":"2025-07-25","current":-3.752298,"twenty":-39.349611,"median":-20.964631,"eighty":-3.646022,"marketCap":70056887},{"date":"2025-08-01","current":-3.845523,"twenty":-39.3019,"median":-20.547303,"eighty":-3.685176,"marketCap":71797431},{"date":"2025-08-08","current":-4.353598,"twenty":-39.293948,"median":-20.408193,"eighty":-3.727127,"marketCap":81283395},{"date":"2025-08-15","current":-4.169718,"twenty":-39.274289,"median":-19.933584,"eighty":-3.76778,"marketCap":94285206},{"date":"2025-08-22","current":-3.772796,"twenty":-39.254519,"median":-19.688096,"eighty":-3.760497,"marketCap":85310069},{"date":"2025-08-29","current":-3.813716,"twenty":-39.233455,"median":-10.865861,"eighty":-3.760497,"marketCap":86235341},{"date":"2025-09-05","current":-4.177901,"twenty":-39.220244,"median":-10.526074,"eighty":-3.773614,"marketCap":94470260},{"date":"2025-09-12","current":-3.764612,"twenty":-39.204768,"median":-9.709606,"eighty":-3.773614,"marketCap":85125014},{"date":"2025-09-19","current":-3.314496,"twenty":-39.138888,"median":-9.122923,"eighty":-3.737606,"marketCap":74947023},{"date":"2025-09-26","current":-3.199921,"twenty":-39.116968,"median":-8.741579,"eighty":-3.623336,"marketCap":72356262},{"date":"2025-10-03","current":-3.34314,"twenty":-39.09097,"median":-8.428681,"eighty":-3.551865,"marketCap":75594714},{"date":"2025-10-10","current":-3.494542,"twenty":-39.075273,"median":-8.291789,"eighty":-3.534152,"marketCap":79018220},{"date":"2025-10-17","current":-3.109897,"twenty":-39.027886,"median":-7.962078,"eighty":-3.498549,"marketCap":70320664},{"date":"2025-10-24","current":-2.897115,"twenty":-38.940184,"median":-7.633919,"eighty":-3.482878,"marketCap":65509250},{"date":"2025-10-31","current":-2.909391,"twenty":-38.804612,"median":-7.450846,"eighty":-3.374238,"marketCap":65786832},{"date":"2025-11-07","current":-2.983046,"twenty":-38.663931,"median":-7.254628,"eighty":-3.361323,"marketCap":67452321},{"date":"2025-11-14","current":-2.621936,"twenty":-38.6419,"median":-7.20399,"eighty":-3.333221,"marketCap":67082212},{"date":"2025-11-21","current":-3.258434,"twenty":-38.625998,"median":-7.137979,"eighty":-3.315314,"marketCap":83366998},{"date":"2025-11-28","current":-3.594765,"twenty":-38.625995,"median":-6.963795,"eighty":-3.314496,"marketCap":91972026},{"date":"2025-12-05","current":-3.276516,"twenty":-38.456214,"median":-6.708179,"eighty":-3.314142,"marketCap":83829634},{"date":"2025-12-12","current":-2.961884,"twenty":-38.413768,"median":-6.632186,"eighty":-3.290836,"marketCap":75779768},{"date":"2025-12-19","current":-2.857006,"twenty":-38.350099,"median":-6.354912,"eighty":-3.258434,"marketCap":73096480},{"date":"2025-12-26","current":-3.066761,"twenty":-38.300453,"median":-6.221623,"eighty":-3.198527,"marketCap":78463057},{"date":"2026-01-02","current":-2.857006,"twenty":-38.248873,"median":-6.028218,"eighty":-3.184173,"marketCap":73096480},{"date":"2026-01-09","current":-2.846157,"twenty":-38.210281,"median":-5.866832,"eighty":-3.139814,"marketCap":72818898},{"date":"2026-01-16","current":-2.560456,"twenty":-38.170115,"median":-5.764162,"eighty":-3.103963,"marketCap":65509250},{"date":"2026-01-23","current":-2.379633,"twenty":-38.109126,"median":-5.691463,"eighty":-3.066761,"marketCap":60882891},{"date":"2026-01-30","current":-1.869712,"twenty":-37.999948,"median":-5.513005,"eighty":-3.019747,"marketCap":47836557},{"date":"2026-02-06","current":-1.663573,"twenty":-37.887707,"median":-5.323443,"eighty":-2.9876,"marketCap":42562507},{"date":"2026-02-13","current":-1.638258,"twenty":-37.814908,"median":-5.250814,"eighty":-2.957395,"marketCap":41914817},{"date":"2026-02-20","current":-1.89141,"twenty":-37.791053,"median":-5.231258,"eighty":-2.930623,"marketCap":48391720},{"date":"2026-02-27","current":-1.591244,"twenty":-37.763222,"median":-5.212816,"eighty":-2.89957,"marketCap":40711963},{"date":"2026-03-06","current":-1.450202,"twenty":-37.64792,"median":-5.171192,"eighty":-2.886661,"marketCap":37103403},{"date":"2026-03-13","current":-1.565929,"twenty":-37.601604,"median":-5.067362,"eighty":-2.872563,"marketCap":40064273},{"date":"2026-03-20","current":-1.452342,"twenty":-37.462974,"median":-5.060142,"eighty":-2.848327,"marketCap":39164381},{"date":"2026-03-27","current":-1.345905,"twenty":-37.39506,"median":-5.023312,"eighty":-2.81779,"marketCap":36294178},{"date":"2026-04-02","current":-1.373373,"twenty":-37.39506,"median":-5.008257,"eighty":-2.777444,"marketCap":37034876},{"date":"2026-04-10","current":-1.383673,"twenty":-37.352614,"median":-4.96552,"eighty":-2.744896,"marketCap":37312637},{"date":"2026-04-17","current":-1.369939,"twenty":-37.352614,"median":-4.878764,"eighty":-2.677991,"marketCap":36942288},{"date":"2026-04-24","current":-1.321871,"twenty":-37.289369,"median":-4.834638,"eighty":-2.621936,"marketCap":35646068},{"date":"2026-05-01","current":-1.266936,"twenty":-37.075389,"median":-4.791246,"eighty":-2.520675,"marketCap":34164673},{"date":"2026-05-08","current":-1.304704,"twenty":-37.013045,"median":-4.759848,"eighty":-2.379633,"marketCap":35183132},{"date":"2026-05-15","current":-1.29097,"twenty":-36.657918,"median":-4.726862,"eighty":-1.989055,"marketCap":34812783},{"date":"2026-05-22","current":-0.952489,"twenty":-36.618159,"median":-4.701084,"eighty":-1.869712,"marketCap":28609441},{"date":"2026-05-29","current":-0.967902,"twenty":-36.524547,"median":-4.684546,"eighty":-1.778577,"marketCap":29072377},{"date":"2026-06-05","current":-0.961737,"twenty":-36.333397,"median":-4.581202,"eighty":-1.73518,"marketCap":28887203},{"date":"2026-06-12","current":-0.752128,"twenty":-36.234746,"median":-4.538149,"eighty":-1.677316,"marketCap":22591274},{"date":"2026-06-18","current":-1.174429,"twenty":-36.1867,"median":-4.529194,"eighty":-1.658046,"marketCap":35275719},{"date":"2026-06-26","current":-1.508594,"twenty":-36.138654,"median":-4.51746,"eighty":-1.640428,"marketCap":45312880},{"date":"2026-07-02","current":-1.661705,"twenty":-35.994244,"median":-4.482916,"eighty":-1.622122,"marketCap":49911799},{"date":"2026-07-10","current":-1.684222,"twenty":-35.726787,"median":-4.41968,"eighty":-1.609687,"marketCap":50588111},{"date":"2026-07-17","current":-1.414026,"twenty":-35.527938,"median":-4.351268,"eighty":-1.601689,"marketCap":42472371},{"date":"2026-07-24","current":-1.202372,"twenty":-35.095242,"median":-4.262561,"eighty":-1.59587,"marketCap":36115042},{"date":"2026-07-31","current":-1.134823,"twenty":-34.627571,"median":-4.241728,"eighty":-1.588961,"marketCap":34086107},{"date":"2026-08-07","current":-1.242902,"twenty":-34.501534,"median":-4.181454,"eighty":-1.572341,"marketCap":37332403},{"date":"2026-08-14","current":-1.459615,"twenty":-34.113333,"median":-4.141074,"eighty":-1.56639,"marketCap":44298951}],"updateTime":1787003820027},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRVO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1144170029","title":"CervoMed 在 AAIC 2026 公布 Neflamapimod 治療路易體痴呆的新臨床、血漿生物標誌物及影像學數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1144170029","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144170029?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 19:32","pubTimestamp":1784028776,"startTime":"0","endTime":"0","summary":"CervoMed 在 2026 年阿尔茨海默病协会国际会议上，公布了其药物 Neflamapimod 用于治疗路易体痴呆的最新研究成果。此次公布的数据涵盖了关键的临床疗效指标、创新的血浆生物标志物分析以及先进的神经影像学发现，为评估该疗法的潜力提供了多维度的证据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170264182","title":"CervoMed宣佈完成Neflamapimod針對非流利變異型原發性進行性失語症（一種額顳葉痴呆）的二期研究入組","url":"https://stock-news.laohu8.com/highlight/detail?id=1170264182","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170264182?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 19:32","pubTimestamp":1783596724,"startTime":"0","endTime":"0","summary":"CervoMed已宣布，其药物Neflamapimod针对非流利变异型原发性进行性失语症（一种额颞叶痴呆）的第二阶段临床试验，现已成功完成患者入组工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132605708","title":"CervoMed完成1000萬美元納斯達克規則下普通股註冊直接發行","url":"https://stock-news.laohu8.com/highlight/detail?id=1132605708","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132605708?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 04:05","pubTimestamp":1782158721,"startTime":"0","endTime":"0","summary":"CervoMed宣布，其已根据纳斯达克市场规则，完成一笔定价为市场价格的普通股注册直接发行，募集资金总额达1000万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146627967","title":"CervoMed宣佈根據納斯達克規則進行1000萬美元普通股市場價註冊直接發行","url":"https://stock-news.laohu8.com/highlight/detail?id=1146627967","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146627967?lang=zh_tw&edition=fundamental","pubTime":"2026-06-19 00:36","pubTimestamp":1781800571,"startTime":"0","endTime":"0","summary":"CervoMed宣布，将根据纳斯达克规则进行一项价值1000万美元的普通股注册直接发行，发行价格将按市场价确定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132953813","title":"CervoMed獲得新美國專利，保護Neflamapimod用於純路易體痴呆患者至2042年","url":"https://stock-news.laohu8.com/highlight/detail?id=1132953813","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132953813?lang=zh_tw&edition=fundamental","pubTime":"2026-06-18 19:03","pubTimestamp":1781780594,"startTime":"0","endTime":"0","summary":"CervoMed成功获得一项新的美国专利，该专利将其在研药物Neflamapimod用于治疗纯路易体痴呆患者的权益保护期延长至2042年。这项专利授权巩固了该公司在这一特定神经退行性疾病治疗领域的知识产权地位，为其核心资产的长期商业化前景提供了法律保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121123878","title":"CervoMed宣佈私募融資計劃 將聚焦戰略合作以推進Neflamapimod進入路易體痴呆症三期臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=1121123878","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121123878?lang=zh_tw&edition=fundamental","pubTime":"2026-06-10 19:30","pubTimestamp":1781091016,"startTime":"0","endTime":"0","summary":"CervoMed公司宣布了一项私募融资计划，并披露了其未来战略重心：公司将致力于寻求战略合作伙伴，以推动其核心候选药物Neflamapimod进入针对路易体痴呆症的第三阶段临床试验。这一举措旨在为关键性临床研究获取必要资源，加速该疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176804788","title":"CervoMed計劃於2026年下半年啓動Neflamapimod針對DLB患者的III期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1176804788","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176804788?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 19:36","pubTimestamp":1779104183,"startTime":"0","endTime":"0","summary":"CervoMed公司宣布，计划在2026年下半年启动一项III期临床试验，旨在评估其候选药物Neflamapimod在路易体痴呆（DLB）患者中的疗效与安全性。这一举措标志着该药物研发进程中的重要一步，公司正积极推进其针对神经退行性疾病的治疗管线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163917918","title":"CervoMed將於2026年路易體痴呆協會年會公布Neflamapimod臨床項目進展並參與生物標誌物專題討論","url":"https://stock-news.laohu8.com/highlight/detail?id=1163917918","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163917918?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 19:31","pubTimestamp":1775561473,"startTime":"0","endTime":"0","summary":"CervoMed宣布，公司计划在2026年路易体痴呆协会年度会议上，详细介绍其核心候选药物Neflamapimod的临床研发项目最新数据与进展。此外，CervoMed的研究专家还将受邀参与一场关于生物标志物的专题小组讨论，分享在该领域的见解与发现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620263228","title":"BUZZ-CervoMed 因實驗性藥物在早期痴呆症患者中顯示出療效而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2620263228","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620263228?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 20:46","pubTimestamp":1773924375,"startTime":"0","endTime":"0","summary":"BUZZ-CervoMed 因实验性药物在早期痴呆症患者中显示出疗效而上涨3月19日 - ** 生物技术公司CervoMed CRVO.O股价上涨8%至4.58美元** 该公司称，新的试验分析表明，其试验性药物neflamapimod对早期路易体痴呆症患者的疗效最佳，路易体痴呆症是一种影响记忆、思维和运动的脑部疾病 。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nL4S4071F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190106082","title":"CervoMed於2026年Ad/Pd™科學會議公布新數據，進一步證實Neflamapimod對無阿爾茨海默病共病理的路易體痴呆患者具有積極療效","url":"https://stock-news.laohu8.com/highlight/detail?id=1190106082","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190106082?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 19:33","pubTimestamp":1773920016,"startTime":"0","endTime":"0","summary":"CervoMed在2026年Ad/Pd™科学会议上公布了最新研究数据，这些数据强化了Neflamapimod药物对不伴有阿尔茨海默病共病理的路易体痴呆患者的治疗效果。新发现突显该疗法在特定患者群体中的显著优势，为精准医疗提供重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186895438","title":"CervoMed確定針對路易體痴呆症患者的三期臨床試驗配方及給藥方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1186895438","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186895438?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 20:32","pubTimestamp":1772627574,"startTime":"0","endTime":"0","summary":"CervoMed已正式确定其针对路易体痴呆症患者的三期临床试验的最终配方及给药方案。这一关键决策标志着该公司在推进神经退行性疾病治疗研究方面迈出了重要一步，为后续临床试验的开展奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616287587","title":"Cervomed Inc.盤中異動 股價大漲5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616287587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616287587?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 03:07","pubTimestamp":1772564827,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日03时07分，Cervomed Inc.股票出现异动，股价快速上涨5.14%。截至发稿，该股报4.09美元/股，成交量5.2395万股，换手率0.57%，振幅7.67%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为1.90%。其相关个股中，Edesa Biotech, Inc.、Onconetix, Inc.、Calcimedica, Inc.涨幅较大，Edesa Biotech, Inc.、Adial Pharmaceuticals, Inc、Onconetix, Inc.较为活跃，换手率分别为296.56%、138.89%、128.97%，振幅较大的相关个股有Edesa Biotech, Inc.、Onconetix, Inc.、Yd Bio Ltd C/Wts 28/08/2030，振幅分别为76.32%、47.36%、43.99%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304030708a69ea6fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304030708a69ea6fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173716197","title":"CervoMed旗下Neflamapimod獲選納入英國Experts-ALS平台，旨在優先推進肌萎縮側索硬化症的潛力療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1173716197","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173716197?lang=zh_tw&edition=fundamental","pubTime":"2026-02-18 19:02","pubTimestamp":1771412559,"startTime":"0","endTime":"0","summary":"CervoMed公司宣布，其研发的候选药物Neflamapimod已被遴选加入英国Experts-ALS平台。该平台的核心目标在于识别并优先推进针对肌萎缩侧索硬化症（ALS）最具前景的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}